Clinical trial
The Optical Coherence Tomography Drug Eluting Stent Investigation(OCTDESI)
NCT00776204 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Optical Coherence Tomography Drug Eluting Stent Investigation(OCTDESI)
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- February 28, 2011
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.